SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-045079
Filing Date
2021-08-19
Accepted
2021-08-19 07:31:20
Documents
58
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck1783328-10q_20210630.htm   iXBRL 10-Q 2555232
2 EX-31.1 ck1783328-ex311_9.htm EX-31.1 41554
3 EX-31.2 ck1783328-ex312_8.htm EX-31.2 41852
4 EX-32.1 ck1783328-ex321_7.htm EX-32.1 14583
5 EX-32.2 ck1783328-ex322_6.htm EX-32.2 16570
  Complete submission text file 0001564590-21-045079.txt   6834226

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ck1783328-20210630.xsd EX-101.SCH 35750
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck1783328-20210630_cal.xml EX-101.CAL 27961
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck1783328-20210630_def.xml EX-101.DEF 131763
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck1783328-20210630_lab.xml EX-101.LAB 290123
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck1783328-20210630_pre.xml EX-101.PRE 234513
11 EXTRACTED XBRL INSTANCE DOCUMENT ck1783328-10q_20210630_htm.xml XML 1006494
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40603 | Film No.: 211188397
SIC: 2836 Biological Products, (No Diagnostic Substances)